Showing 1 - 13 results of 13 for search 'Alexey V Danilov', query time: 0.05s
Refine Results
-
1
The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia by Max J. Gordon, Alexey V. Danilov
Published 2021-01-01
Article -
2
Refractory Autoimmune Cytopenias Treated With Venetoclax by Max J. Gordon, Edward Maldonado, Alexey V. Danilov
Published 2019-06-01
Article -
3
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet? by Alexey V. Danilov, John M. Pagel, Jennifer R. Brown, Brian T. Hill
Published 2019-08-01
Article -
4
-
5
Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance. by Alexey V Danilov, Divas Neupane, Archana Sidalaghatta Nagaraja, Elena V Feofanova, Leigh Ann Humphries, James DiRenzo, Murray Korc
Published 2018-01-01
Article -
6
DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. by Alexey V Danilov, Divas Neupane, Archana Sidalaghatta Nagaraja, Elena V Feofanova, Leigh Ann Humphries, James DiRenzo, Murray Korc
Published 2011-01-01
Article -
7
-
8
Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells. by Cody Paiva, J Claire Godbersen, Ryan S Soderquist, Taylor Rowland, Sumner Kilmarx, Stephen E Spurgeon, Jennifer R Brown, Sreesha P Srinivasa, Alexey V Danilov
Published 2015-01-01
Article -
9
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma by Elana Thieme, Nur Bruss, Duanchen Sun, Edward C. Dominguez, Daniel Coleman, Tingting Liu, Carly Roleder, Melissa Martinez, Krystine Garcia-Mansfield, Brian Ball, Patrick Pirrotte, Lili Wang, Zheng Xia, Alexey V. Danilov
Published 2023-03-01
Article -
10
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma by Elana Thieme, Tingting Liu, Nur Bruss, Carly Roleder, Vi Lam, Xiaoguang Wang, Tamilla Nechiporuk, Geoffrey Shouse, Olga V. Danilova, Daniel Bottomly, Shannon K. McWeeney, Jeffrey W. Tyner, Stephen E. Kurtz, Alexey V. Danilov
Published 2022-03-01
Article -
11
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma by Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D. Lynne Smith, Alex F. Herrera, Stephen E. F. Spurgeon, Byung Park, Lionel D. Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V. Danilov
Published 2023-01-01
Article -
12
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells by Walter Hanel, Pushpa Lata, Youssef Youssef, Ha Tran, Liudmyla Tsyba, Lalit Sehgal, Bradley W. Blaser, Dennis Huszar, JoBeth Helmig-Mason, Liwen Zhang, Morgan S. Schrock, Matthew K. Summers, Wing Keung Chan, Alexander Prouty, Bethany L. Mundy-Bosse, Selina Chen-Kiang, Alexey V. Danilov, Kami Maddocks, Robert A. Baiocchi, Lapo Alinari
Published 2022-07-01
Article -
13
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study by Narendranath Epperla, Lei Feng, Nirav N. Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M. Stephens, Catherine J. Lee, Thomas Ollila, Geoffrey Shouse, Alexey V. Danilov, Kevin A. David, Pallawi Torka, Hamza Hashmi, Brian Hess, Stefan K. Barta, Jason T. Romancik, Jonathon B. Cohen, Kaitlin Annunzio, Adam S. Kittai, John Reneau, Joanna Zurko, Imran A. Nizamuddin, Jane N. Winter, Leo I. Gordon, Shuo Ma, Romil Patel, Loretta Nastoupil, Sairah Ahmed, Reem Karmali
Published 2023-11-01
Article